Pandemic Agreement Adopted by WHO Members
The World Health Parliament, a group aligned with the World Health Organization (WHO), officially approved a pandemic agreement on Tuesday. This international legal document encourages signatory countries to share medical technology, enhance vaccination efforts, and promote equity in healthcare.
This agreement has sparked significant debate—originally regarded as a binding document discussed since 2021, it aims to address the WHO’s shortcomings during the Wuhan Coronavirus pandemic. Critics have pointed out that the organization collaborated closely with the Chinese Communist Party early in the outbreak, which some argue delayed the response. Additionally, key warnings from Taiwan about an emerging virus in Wuhan were reportedly ignored.
The Wuhan Coronavirus has claimed over 7 million lives globally.
Director Tedros Adhanom Ghebreyesus has argued that the UN body lacked the authority to effectively manage the virus’s spread. He criticizes the economic disparities related to mass fatalities and suggests that countries leading in medical innovation, notably the United States, should relax intellectual property laws during crises to ensure rapid and affordable access to vaccines and treatments. The new agreement intends to create frameworks for pathogen access and benefit sharing, expanding the pool of scientists involved in monitoring and developing medical responses.
The final draft of the document was completed in April, with a vote that passed 124 to 11, although countries like Iran, Israel, and Russia abstained. Notably, some of the strongest opponents, including the U.S. and Argentina, were absent from the discussions.
The agreement emphasizes the need to adopt equitable principles for pandemic prevention and management while also referencing climate change and other socio-political issues.
Specifically, it outlines that participating manufacturers must provide certain vaccines and treatments to the WHO under a legally binding agreement, aiming to ensure that targeted populations receive timely access based on public health needs, particularly in developing nations.
Furthermore, signatories are required to amend their national laws to comply with the WHO’s mandates, including enhancing biological risk management protocols. This comes in light of ongoing investigations into the origins of the virus, particularly the theory that a laboratory leak might have played a role, which the WHO initially dismissed after reviewing Wuhan in 2021.
If a country wishes to withdraw from this agreement, it will take three years, during which it must adhere to the terms for at least two years before submitting a withdrawal request, which becomes effective one year after submission.
However, even with the agreement in place, it won’t automatically hold legal weight—the provisions will only take effect once they are ratified by the signing countries. The WHO has stated it will soon open the agreement for signatures, with non-signatory countries not bound by its regulations.
Tedros framed the agreement as a significant step forward in global public health, asserting that it reflects collective responsibility and reinforces international collaboration. He labeled it a success for science and a proactive measure against future pandemics.
This treaty also emerges amidst concerns that it could undermine the sovereignty of participating nations, granting the WHO expanded control over national health policies. Tedros has addressed these worries, characterizing them as misinformation and stressing that the agreement reaffirms national sovereignty rather than diminishing it.
